Trial intelligence / Profile preview

CR845 in patients with pain following bunionectomy surgery

NCT01789476Phase 2Completed

Sponsor
Cara Therapeutics, Inc.
Start
May 2013
Primary completion
Aug 2013
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of difelikefalin in acute pain, sponsored by Cara Therapeutics, Inc.. Started May 2013; status: completed.

02

Drugs

difelikefalin
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT01789476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01789476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call